Synapse - Oliver Surriga

Search Within

Oliver Surriga

Results (4)

Export to EndNote / Excel | PubMed

Suppression of oncogene transcription - PNA as targeted cancer therapy for BRAF-V600E mutant melanoma

Meeting Abstract

Rothman, J. H.; Surriga, O.; Ambrosini, G.; Vasudeva, S.; Schwartz, G. K.
Annals of Oncology (2016)

Fulltext@MSK | Save

PNA as novel targeted cancer therapy for BRAF(V600E) mutant melanoma

Meeting Abstract

Rothman, J. H.; Surriga, O.; Vasudeva, S. D.; Ambrosini, G.; Ouerfelli, O.; Schwartz, G. K.
Cancer Research (2014)

Fulltext@MSK | Save

Crizotinib, a selective c-Met inhibitor, prevents metastasis to the liver and lungs in a primary uveal melanoma mouse model

Meeting Abstract

Surriga, O.; Vinagolu, R.; Ambrosini, G.; Schwartz, G.
Cancer Research (2013)

Fulltext@MSK | Save

Crizotinib, a c-Met Inhibitor, Prevents Metastasis in a Metastatic Uveal Melanoma Model

Journal Article

Surriga, O.; Rajasekhar, V. K.; Ambrosini, G.; Dogan, Y.; Huang, R.; Schwartz, G. K.
Molecular Cancer Therapeutics (2013)

Fulltext@MSK | Save